Found: 13
Select item for more details and to access through your institution.
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 243, doi. 10.2147/PGPM.S143250
- By:
- Publication type:
- Article
CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 107, doi. 10.2147/PGPM.S126305
- By:
- Publication type:
- Article
Supporting frontline clinicians in the time of the pandemic: Rapid response pharmacology team.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 725, doi. 10.1111/bcp.14526
- By:
- Publication type:
- Article
Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs.
- Published in:
- Drug Metabolism & Personalized Therapy, 2024, v. 39, n. 2, p. 69, doi. 10.1515/dmpt-2024-0040
- By:
- Publication type:
- Article
Pharmacogenetic predictors of development of secondary to enalapril dry cough in hypertensive patients.
- Published in:
- Drug Metabolism & Personalized Therapy, 2023, v. 38, n. 3, p. 247, doi. 10.1515/dmpt-2023-0008
- By:
- Publication type:
- Article
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
- Published in:
- Drug Metabolism & Personalized Therapy, 2023, v. 38, n. 3, p. 255, doi. 10.1515/dmpt-2023-0007
- By:
- Publication type:
- Article
CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study.
- Published in:
- Drug Metabolism & Personalized Therapy, 2023, v. 38, n. 2, p. 163, doi. 10.1515/dmpt-2022-0115
- By:
- Publication type:
- Article
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
- Published in:
- Drug Metabolism & Personalized Therapy, 2022, v. 37, n. 1, p. 41, doi. 10.1515/dmpt-2021-0118
- By:
- Publication type:
- Article
Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel.
- Published in:
- Drug Metabolism & Personalized Therapy, 2019, v. 34, n. 3, p. 1, doi. 10.1515/dmpt-2018-0039
- By:
- Publication type:
- Article
Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA).
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 4, p. 195, doi. 10.1515/dmpt-2018-0015
- By:
- Publication type:
- Article
The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes.
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 3, p. 109, doi. 10.1515/dmpt-2018-0006
- By:
- Publication type:
- Article
Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia).
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 2, p. 91, doi. 10.1515/dmpt-2018-0004
- By:
- Publication type:
- Article
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
- Published in:
- Drug Metabolism & Personalized Therapy, 2017, v. 32, n. 3, p. 129, doi. 10.1515/dmpt-2017-0021
- By:
- Publication type:
- Article